Blog

Caplin Point Laboratories – A high quality Pharmaceutical stock

Dear Readers, In this post we would like to discuss a very small cap stock Caplin Point Laboratories (BSE Code – 524742). As mentioned in one of our previous posts, small and micro cap stocks are fraught with risks, however quick decision making and keeping a strong tab on the performance of such companies can also result in substantial gains. Caplin Point – Basic details Caplin Point is a debt free company with a market cap of 215 crores. The company’s…

Read More

[Report]: Feb’14 Pharmaceutical alpha stock – Good Company and great valuations

Feb’14 Alpha stock – A good Pharma company with great valuations Dear Readers, On 25th Feb’14 we released long/medium term investment recommendation for our Alpha and Alpha + members and would like to share with you details on the same especially if you like our research and our focus on high quality companies run by good management. Our last recommendation from Pharmaceutical Industry was IPCA Laboratories in Nov’12 at Rs 445 and the stock has appreciated by 100% since then to current…

Read More

CARE Rating – Getting re-rated with PE funds negotiating for a majority stake at 900-1000

Dear Readers, CARE Rating (NSE Code – CARERATING) was recommended to Alpha and Alpha plus members in Aug’13 when the stock was around 525. The detailed report on the same was also made public on 16th Nov’13 when the stock was around 700 (CMP – 850). In case you have invested in CARE, here’s an important update regarding the latest developments in the company. The Company recently informed exchanges that its principal shareholders, IDBI, along with four other shareholders, who hold…

Read More

Fluidomat Ltd – Can this micro cap stock couple your portfolio to high returns?

Dear Readers, In this post we would like to discuss a micro cap stock Fluidomat (BSE Code – 522017). While small and micro cap stocks are fraught with risks, quick decision making and keeping a strong tab on the performance of such companies can also result in substantial gains. Also, until one is really confident of the business model and prospects of such companies, it’s important to not get emotionally attached and exit at first sight of deterioration in performance. Note: Please…

Read More
Insider Bets - Premium Subscription based on theme of Betting with PromotersDetails
Copy Protected by Chetan's WP-Copyprotect.